First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects

Abstract

Our findings do not show that there are significantly increased risks of craniosynostosis, omphalocele, or heart defects associated with SSRI use overall. They suggest that individual SSRIs may confer increased risks for some specific defects, but it should be recognized that the specific defects implicated are rare and the absolute risks are small.